Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "Short ragweed pollen-specific IgE-mediated immune response" does **not refer to a single molecule or receptor**, but rather describes an **immunological process**. This process involves the production of immunoglobulin E (**IgE**) antibodies that are specific to allergens found in short ragweed (*Ambrosia artemisiifolia*) pollen. When individuals sensitized to these allergens are exposed again, their preformed allergen-specific IgE binds and cross-links on high-affinity FcεRI receptors located on mast cells and basophils[2]. This triggers degranulation of these cells and release of mediators such as histamine, prostaglandins, leukotrienes, and cytokines—leading to immediate allergic symptoms like sneezing, itching, nasal congestion ("hay fever"), or even asthma attacks[2]. The late-phase reaction involves recruitment of additional inflammatory cells including eosinophils and Th2 lymphocytes. Chronic exposure can lead to persistent inflammation characteristic of allergic diseases such as perennial rhinitis or asthma[2]. The level of allergen-specific serum IgE can remain elevated long after exposure ceases due to immunological memory[1]. Therapeutic interventions do not directly target this "response," but rather components within it—such as blocking IgE with monoclonal antibodies like omalizumab; inhibiting mast cell activation; or using allergen immunotherapy which aims at inducing protective antibody responses such as specific IgG4 that block allergen-IgE interactions[1]. Measurement of short ragweed pollen-specific serum IgE serves as a diagnostic biomarker. Because this entry refers broadly to an **immune mechanism** rather than a discrete molecular entity suitable for direct pharmacologic targeting or structural annotation, it should be flagged as incorrect if used where only canonical molecules/receptors/targets are appropriate.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Short ragweed pollen-specific IgE-mediated immune response.